Peptide inhibitors of protein kinase C
US7833984B2 · kind B2 · utility
3Cited by
10References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 16, 2007 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Oct 5, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PKC V5 isozyme-specific peptides are described. The sequences and compositions comprising the sequences are useful for treating disease states associated with the PKC isozyme from which they are respectively derived. Methods of treatment, pharmaceutical formulations and methods of identifying compounds that mimic the activity of the peptides are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.